Hypoactive Sexual Desire Disorder
📧 Sign up to get email alerts when something new happens for Hypoactive Sexual Desire Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-04-02FDA Approved: ADDYI — Supplemental Application (Sprout Pharmaceuticals, Inc.)
FDA approved a supplemental application for ADDYI (flibanserin) by Sprout Pharmaceuticals, Inc., updating regulatory status for the product.
-
CLINICAL_TRIALS research · 2017-10-20Clinical Trial Update: Role of Progesterone in Hypoactive Sexual Desire Disorder in Menopausal Women [Phase 4]
Phase 4 clinical trial investigating the role of progesterone in hypoactive sexual desire disorder among menopausal women. Current status is…
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: Study of the Efficacy and Safety of BP101 in Female Patients With Decrease or Loss of Sexual Desire [Phase 2]
Phase 2 study of BP101 in women with Hypoactive sexual desire disorder has completed. The update reports on efficacy and safety findings fro…
-
FDA approval · 2017-06-16FDA Approved: ADDYI — Supplemental Application (Sprout Pharmaceuticals, Inc.)
FDA approved a supplemental application for ADDYI (flibanserin) from Sprout Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: 6-mo. Min Eff Dose of Flibanserin: 25 v 50 mg Bid v 50 mg hs v Pbo in Younger Women in NA [Phase 3]
Phase 3 trial evaluating the minimum effective dose of flibanserin (25 mg BID, 50 mg BID, 50 mg at bedtime) versus placebo over six months i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: Uptitration Trial of Flibanserin Versus Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder [Phase 3]
This is a Phase 3 uptitration trial comparing Flibanserin to placebo in premenopausal women with hypoactive sexual desire disorder. Results …
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: 24-week Placebo-controlled Trial of Flibanserin Once Daily in Premenopausal Women With Hypoactive Sexual Desire Disorder [Phase 3]
A Phase 3, 24-week, placebo-controlled trial of flibanserin in premenopausal women with hypoactive sexual desire disorder has completed and …
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: The Effect of Individualised Homeopathic Treatment on Low Sexual Desire in Perimenopause [Phase 2]
University of Johannesburg completed a Phase 2 trial evaluating individualized homeopathic treatment for hypoactive sexual desire disorder i…
-
FDA approval · 2016-04-08FDA Approved: ADDYI — Supplemental Application (Sprout Pharmaceuticals, Inc.)
The FDA has approved a supplemental application for ADDYI (flibanserin) from Sprout Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Efficacy and Safety of Oral DHEA Therapy for Postmenopausal Women on Sexual Function, Wellbeing and Vasomotor Symptoms [Phase 3]
A Phase 3 trial evaluating oral dehydroepiandrosterone (DHEA) for postmenopausal women has completed, assessing effects on sexual function, …
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: Effects of Tribulus Terrestris in Women With Hypoactive Sexual Desire Disorder [Phase 4]
Phase 4 clinical trial evaluating Tribulus Terrestris in women with hypoactive sexual desire disorder has completed.
-
CLINICAL_TRIALS research · 2015-09-25Clinical Trial Update: Genetic Polymorphism of the Androgen Receptor-Gene and Sexual Function in Middle Aged Women
This completed clinical trial investigates whether androgen receptor gene polymorphisms influence sexual function and libido in middle-aged …
-
FDA approval · 2015-08-18FDA Approved: ADDYI — Original Application (Sprout Pharmaceuticals, Inc.)
FDA approved ADDYI (flibanserin) in Sprout Pharmaceuticals' original NDA for hypoactive sexual desire disorder in premenopausal women.
-
CLINICAL_TRIALS research · 2015-04-03Clinical Trial Update: Effects of Tribulus Terrestris in Postmenopausal Women With Hypoactive Sexual Desire Disorder [Phase 4]
Phase 4 trial evaluating Tribulus Terrestris for hypoactive sexual desire disorder in postmenopausal women; the study has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Surveillance Study of Women Taking Intrinsa®
The surveillance study of women taking Intrinsa (testosterone transdermal patch) has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-03-24Clinical Trial Update: Lybridos in Pre-and Postmenopausal Women With Hypoactive Sexual Desire Disorder [Phase 2]
A Phase 2 clinical trial of Lybridos in pre- and postmenopausal women with hypoactive sexual desire disorder has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: Efficacy and Safety of Oral Dehydroepiandrosterone as a Concomitant Therapy to Oral Contraceptives in Women Complaining of Reduced Libido [Phase 2]
Phase 2 trial evaluated the efficacy and safety of adding oral dehydroepiandrosterone (DHEA) to oral contraceptives in women with reduced li…
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: Effects of Early Abuse on Adult Intimate Relationships [NA]
This clinical trial update indicates the study on the effects of early abuse on adult intimate relationships has completed. It included cond…
-
CLINICAL_TRIALS trial_result · 2014-10-28Clinical Trial Update: Phase 1b/2a Unblinded Study of Responses in Premenopausal Women With HSDD to Lorexys Evaluating Efficacy and Safety [Phase 1, Phase 2]
Phase 1b/2a unblinded study evaluating efficacy and safety of Lorexys in premenopausal women with hypoactive sexual desire disorder and sexu…
-
CLINICAL_TRIALS trial_result · 2014-10-17Clinical Trial Update: Acupuncture for Sexual Dysfunction [NA]
This clinical trial update notes that an acupuncture study for Hypoactive Sexual Desire Disorder and related Female Sexual Dysfunction has c…
-
CLINICAL_TRIALS trial_result · 2014-06-20Clinical Trial Update: Flibanserin Evaluation Over 28 Additional Weeks in Hypoactive Sexual Desire Disorder [Phase 3]
This update reports the results of an additional 28 weeks of evaluation in a Phase 3 trial of flibanserin for hypoactive sexual desire disor…
-
CLINICAL_TRIALS trial_result · 2014-06-17Clinical Trial Update: Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women in North America [Phase 3]
Phase 3 study of flibanserin for hypoactive sexual desire disorder in postmenopausal women was terminated, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-06-13Clinical Trial Update: A One-year Safety Study of Flibanserin to Treat Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (HSDD). [Phase 3]
A Phase 3 one-year safety study of flibanserin for hypoactive sexual desire disorder in pre-menopausal women was terminated; results were po…
-
CLINICAL_TRIALS trial_result · 2014-06-12Clinical Trial Update: Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women [Phase 3]
Phase 3 clinical trial evaluating flibanserin for hypoactive sexual desire disorder in postmenopausal women has completed and results were p…
-
CLINICAL_TRIALS trial_result · 2014-06-02Clinical Trial Update: Flibanserin Versus Placebo in Premenopausal Women With HSDD [Phase 3]
Phase 3 trial of Addyi (flibanserin) vs placebo in premenopausal women with hypoactive sexual desire disorder completed; results were posted…